According to the reports of The Fly, Exane BNP Paribas cut down the rating of Nucor (NYSE:NUE) from ‘outperform’ to ‘neutral’ in a research note issued on Thursday. The present price target on the company’s stock is $48.00. The price target of the company’s stock indicates a 1.82% potential...
After insider selling activity on Thursday, the stock price of Bloom Energy Co. (NYSE:BE) gapped down. Previously, the closing price of the stock was $20.73 but $19.20 was the opening price.$18.76 is the last traded price of the shares of Bloom Energy. 116,881 of the company’s shares were traded....
In the previous session, 12,886,398 shares of Camber Energy, Inc. (NYSE:CEI) were acquired. The company has a beta of 1.06. The $1.08 per share price level of the firm is currently traded at -$0.06 or -5.26%. This indicates a $25.78 Million market valuation. Compared to $6.5, the 52-week high,...
Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. This is up from the earlier $120.00. The research firm further announces the rating of “equal weight” to NASDAQ: ALXN stocks. Wall Street Analysts Rates NASDAQ: ALXN Stocks At “Buy” Several Wall Street analysts...
Analysts at Morgan Stanley trimmed the price target of Amgen (NASDAQ: AMGN) to $273.00 on Tuesday. This is down from the earlier $281.00. Morgan Stanley analysts issued a note to several investors informing this cut in Amgen’s PT. The research firm further announces the rating of “overweight” to NASDAQ:...
Five Wall Street analysts covering NYSE: MCB reports a “Hold’ rating consensus on Metropolitan Bank Holding Corp this quarter. Out of the five research firms, one posted a “sell” rating and three announced a “buy” rating making up the average consensus of a “hold” rating. Several analysts suggest that the...
Qiagen (NYSE: QGEN) posted an update on its Q3 earnings guidance this Tuesday. The EPS guidance stands at $0.58 for this quarter beating the Thomas Reuters estimate of $0.56. Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. NYSE: QGEN Quarterly Earnings Report Estimates NYSE: QGEN posted...
According to reports by Benzinga, a research report on Tuesday suggested that Morgan Stanley increased the price target on Ascendis Pharma A/S (NASDAQ:ASND) from $179.00 to $194.00. The company’s stock has received an ‘overweight’ rating from the brokerage. The price target set by Morgan Stanley indicates a 21.33% potential...
Morgan Stanley stock analysts’ dropped the price target on AVROBIO (NASDAQ:AVRO) from $35.00 to $34.00 suggested a research note that was issued to investors on Tuesday, according to Benzinga. The company’s stock has an ‘overweight’ rating, currently. The new price target indicates a 124.72% potential shift from the current...
Investment analysts at Zelman & Associates lowered the rating of Meritage Homes (NYSE:MTH) from ‘buy’ to ‘hold’ in a research note given to investors and clients on Tuesday, as per the reports of The Fly.  Meritage Homes (NYSE:MTH)- Analysts’ Opinion Several comments were bestowed upon the company by various brokerages. In...